emaglutide had a superior Novo Nordisk ® Data from STEP 1 • Average age 46 • 74.1% women • Average BMI - 37.9 kg/m 2 Improvements in lipid profiles as well as C-reactive protein Semaglutide improved health-related quality of life as measured by SF-36 and IWQoL-lite-CT
Download PDF file